Credit Suisse Speculates about 'Outside Interest' in Omnicare (OCR)
Get Alerts OCR Hot Sheet
Price: $97.90 --0%
Rating Summary:
2 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 39
Rating Summary:
2 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 39
Join SI Premium – FREE
Credit Suisse analyst Glen Santangelo put out a note today that raises M&A speculation at Omnicare (NYSE: OCR). Santangelo believes the company's decision to adopt a senior executive change-in-control provision signals outside interest.
Clearly a change-in-control provision is not necessarily a harbinger of M&A, but it a good predictor. Potential buyers could include Cardinal Health (NYSE: CAH) or McKesson Corp (NYSE: MCK). PBM or a drug retailer would also make sense, thinks Santangelo.
Credit Suisse has an Outperform rating on Omnicare with a price target of $52.00.
For an analyst ratings summary and ratings history on Omnicare (NYSE: OCR) click here. For more ratings news on Omnicare click here.
Shares of Omnicare closed at $45.41 yesterday.
Clearly a change-in-control provision is not necessarily a harbinger of M&A, but it a good predictor. Potential buyers could include Cardinal Health (NYSE: CAH) or McKesson Corp (NYSE: MCK). PBM or a drug retailer would also make sense, thinks Santangelo.
Credit Suisse has an Outperform rating on Omnicare with a price target of $52.00.
For an analyst ratings summary and ratings history on Omnicare (NYSE: OCR) click here. For more ratings news on Omnicare click here.
Shares of Omnicare closed at $45.41 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Double Upgrades Hemnet Group AB (HEM:SS) to Buy
- RBC Capital Starts Vestas Wind Systems A/S (VWS:DC) (VWDRY) at Outperform, 'Breezing towards 10% margins'
- RBC Capital Upgrades Vistry Group PLC (VTY:LN) to Sector Perform, 'Veni Vidi Vistry'
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Mergers and Acquisitions, RumorsRelated Entities
Credit SuisseSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!